JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2017. Vol. 62. No. 6. P. 39-45
DIAGNOSTIC RADIOLOGY
DOI: 10.12737/article_5a2536051fdc29.99266085
X-Ray Fluorescence Analysis in the Diagnosis of Thyroid Cancer
V.E. Zaichik, G.A. Davydov
A.F. Tsyb Medical Radiological Research Center, Obninsk, Russia, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. ; This email address is being protected from spambots. You need JavaScript enabled to view it.
V.E. Zaichick – Leading Researcher, Prof., Dr. Sc. Biol., PhD Tech., Fellow of the Royal Society of Chemistry;
G.A. Davydov – Head of the Nuclear Medicine Department, PhD Med.
Abstract
Purpose: Wide distribution of thyroid nodules and high risk of their transformation into malignant tumours specify the urgency of the methods for differential diagnostics used to make true diagnoses in time and to determine the adequate volume of surgical intervention. The aim of the study was to investigate new possibilities of differential diagnosis of benign and malignant thyroid nodules using energy dispersive X-ray fluorescence analysis (EDXRF) of trace element contents in tissue of thyroid lesions.
Material and methods: In the samples of thyroid tissue taken from people with intact thyroid gland (mostly died from trauma, n = 92, mean of age 44 years), as well as in patients with nodular goiter (n = 79, mean of age 44 years) and thyroid cancer (n = 40, mean of age 46 years) the contents of bromine (Br), copper (Cu), iron (Fe), iodine (I), rubidium (Rb), strontium (Sr), and zinc (Zn) were measured. To determine these element contents, the methods of EDXRF was developed using encapsulated sources with 109Cd and 241Am radionuclides to excite the fluorescence in the samples of thyroid tissue.
Results: The accuracy of the developed methods and the reliability of the results obtained in the study were confirmed by the measurements of international certified reference material IAEA H-4 Animal Muscles and the good agreement with data of its certificate. It was found that the Br, Cu, I, Rb, Sr, and Zn contents in malignant and benign thyroid nodules differ from the normal level of these elements in thyroid tissue. The cancer tissue differs for considerably lower content of iodine in comparison with the normal thyroid (almost 23 times on an average) and with the benign thyroid nodules (20 times), and also somewhat lower content of zinc (25 %). At the same time the higher levels of Cu, Rb, and Sr are a more typical composition of thyroid cancer tissue. Finally, it was shown that the level of I content, the ratios I/Cu and I/Rb, as well as the multiplication of the ratios (I/Cu) (I/Rb) and (I/Br) (I/Cu) (I/Rb) are highly informative markers of thyroid cancer.
Conclusion: The method of EDXRF analysis allow to determine the Br, Cu, Fe, I, Rb, Sr, and Zn contents in the tissue specimen, obtained by the large-needle biopsy of thyroid nodes, for a few minutes. It provides in vitro estimation of these element contents in the biopsy specimens prior to histologic study. The use of the proposed markers such as the level of I content, the ratios I/Cu and I/Rb, as well as the multiplication of the ratios (I/Cu) (I/Rb) and (I/Br) (I/Cu) (I/Rb) allow the differentiation of thyroid cancer from benign nodules and normal tissue with sensitivity in the range of 86–100 %, specificity of 89–99 %, and accuracy within 90–99 %.
Key words: thyroid goiter, thyroid cancer, chemical elements of thyroid tissue, X-ray fluorescence analysis
REFERENCES
- Shevchenko S.P., Karpinskaya E.V., Sidorov S.V. et al. Fonovaya patologiya schitovidnoy zhelezy kak prognosticheskiy faktor zabolevaemosti rakom schitovidnoy zhelezy. Byul. SO RAMN. 2011. Vol. 31. 6. P. 103–107. (In Russ.).
- Zaychik V.E., Matveenko E.G., Vtyurin B.M., Medvedev V.S. Intratireoidny yod v diagnostike raka schitovidnoy zhelezy. Vopr. onkol. 1982. Vol. 28. No. 3. P. 18–24. (In Russ.).
- Zaychik V.E., Agadzhanyan N.A. Nekotorye metodologicheskie voprosy meditsinskoy elementologii. Vestn. vosstanov. med. 2004. Vol. 3. No. 9. P. 19–24. (In Russ.).
- Zaichick V. Medical elementology as a new scientific discipline. J. Radioanal. Nucl. Chem. 2006. Vol. 269. No. 2. P. 303–309.
- Zaichick S., Zaichick V. Neutron activation analysis of Ca, Cl, Mg, Na, and P content in human bone affected by osteomyelitis or osteogenic sarcoma. J. Radioanal. Nucl. Chem. 2012. Vol. 293. 1 No.. P. 241–246.
- Zaichick V., Zaichick S. The distinction between chondroma and chondrosarcoma using chemical element mass fractions in tumors determined by neutron activation analysis as diagnostic markers. J. Radioanal. Nucl. Chem. 2016. Vol. 309. No. 1. P. 285–293.
- Zaichick V., Zaichick S. The silver, cobalt, chromium, iron, mercury, rubidium, antimony, selenium and zinc contents in human bone affected by Ewing’s sarcoma. J. Cancer Tumor Int. 2015. Vol. 2. No. 1. P. 21–31.
- Zaichick S., Zaichick V. The content of silver, cobalt, chromium, iron, mercury, rubidium, antimony, selenium, and zinc in osteogenic sarcoma. J. Cancer Ther. 2015. Vol. 6. No. 6. P. 493–503.
- Zaichick V., Zaichick S. The silver, cobalt, chromium, iron, mercury, rubidium, antimony, selenium, and zinc contents in human bone affected by chondrosarcoma. J. Hematol. Oncol. Res. 2015. Vol. 1. No. 4. P. 25–36.
- Zaichick S., Zaichick V. Trace elements of normal, benign hypertrophic and cancerous tissues of the human prostate gland investigated by neutron activation analysis. Appl. Radiat. Isot. 2012. Vol. 70. No. 1. P. 81–87.
- Zaichick V., Zaichick S. Instrumental effect on the contamination of biomedical samples in the course of sampling. J. Anal. Chem. 1996. Vol. 51. No. 12. P. 1200–1205. (In Russ.).
- Zaichik V.E., Tsislyak Yu.V. Usovershenstvovanny adsorbtsionno-kriogenny liofilizator dlya konservatsii biopreparatov. Lab. delo. 1981. No. 2. P. 100–101. (In Russ.).
- Zaichik V.E. Ispolzovanie rentgenovskoy fluorestsentsii, vozbuzhdaemoy izlucheniem radionuklidnyh istochnikov v meditsine. V sb.: Yaderno-fizicheskie metody elementnogo analiza v biologii i meditsine. Pod. red. A.F. Tsyba. Obninsk: NIIMR. 1980. P. 88–102. (In Russ.).
- Zaichik V.E. Razvitie i ispolzovanie aktivatsionnyh i rentgenofluorestsentnyh metodov analiza himicheskih elementov v organizme cheloveka. Med. radiol. 1987. Vol. 32. No. 9. P. 47–50.
- Genes V.S. Nekotorye prostye metody kiberneticheskoy obrabotki dannyh diagnosticheskih i fiziologicheskih issledovaniy. Moscow: Nauka.1967. 208 p. (In Russ.).
For citation: Zaichik VE, Davydov GA. X-Ray Fluorescence Analysis in the Diagnosis of Thyroid Cancer. Medical Radiology and Radiation Safety. 2017;62(6):39-45. Russian. DOI: 10.12737/article_5a2536051fdc29.99266085
PDF (RUS) Full-text article (in Russian)